Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Magnesium ascorbyl phosphate (MAP) is a stable, water-soluble derivative of Vitamin C (L-ascorbic acid). Unlike pure ascorbic acid, which is highly prone to oxidation, MAP remains stable in various formulations and is hydrolyzed by phosphatases in the body to release active ascorbic acid. In the context of oral care, it is used in dentifrices to treat gingivitis and periodontal inflammation. Its therapeutic effects are attributed to its ability to promote collagen synthesis in gingival tissues and its potent antioxidant properties, which help neutralize reactive oxygen species and reduce tissue damage. It is also widely used in dermatological applications for skin lightening and as an anti-aging agent.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium ascorbyl phosphate.